Synagis 100Mg - 1 Fa C/1Ml
SYNAGIS is a powdered lyophilized formulation for injectable solution containing 100 mg per vial, used for preventing respiratory syncytial virus (RSV) infection in high-risk infants.
- The description claims that palivizumabe neutralizes and inhibits RSV replication and fusion.
AI Readiness
Good foundation, but some important product data is still missing.
80%